Inventor
MAROM EHUD
IL36 patents
⚠️ This page may combine multiple inventors who share the name “MAROM EHUD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MAPI PHARMA LTD
22 patentsUS9200114B2Dec 1, 2015
Random pentapolymer for treatment of autoimmune diseases
MAPI PHARMA LTD8 citations83
US9006188B2Apr 14, 2015
Co-crystals of dapagliflozin
MAPI PHARMA LTD8 citations83
US8377885B2Feb 19, 2013
Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
MAPI PHARMA LTD14 citations83
US11471421B2Oct 18, 2022
Process for preparing microparticles containing glatiramer acetate
MAPI PHARMA LTD2 citations71
US10493122B2Dec 3, 2019
Sublingual delivery of glatiramer acetate
MAPI PHARMA LTD5 citations71
US11931357B2Mar 19, 2024
Depot systems comprising Cariprazine or salts thereof
MAPI PHARMA LTD2 citations69
US11167003B2Nov 9, 2021
Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems
MAPI PHARMA LTD3 citations66
USRE50301EFeb 18, 2025
Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
MAPI PHARMA LTD0 citations62
USRE49251EOct 18, 2022
Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
MAPI PHARMA LTD1 citations62
US12370233B2Jul 29, 2025
Depot systems comprising glatiramer acetate
MAPI PHARMA LTD0 citations59
US12251380B2Mar 18, 2025
Depot systems comprising cariprazine or salts thereof
MAPI PHARMA LTD0 citations59
US11865213B2Jan 9, 2024
Semaglutide depot systems and use thereof
MAPI PHARMA LTD1 citations58
US12343371B2Jul 1, 2025
Method for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using a sustained release depot formulation comprising glatiramer acetate
MAPI PHARMA LTD0 citations56
US9994522B2Jun 12, 2018
Amorphous form of apremilast
MAPI PHARMA LTD0 citations51
US9453024B2Sep 27, 2016
Polymorphs of darunavir
MAPI PHARMA LTD0 citations51
US9102592B2Aug 11, 2015
Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium
MAPI PHARMA LTD0 citations51
US9096574B2Aug 4, 2015
Polymorphs of perampanel
MAPI PHARMA LTD0 citations51
US8975244B2Mar 10, 2015
Process and intermediates for the preparation of abiraterone acetate
MAPI PHARMA LTD1 citations51
US12097292B2Sep 24, 2024
Process for preparing microparticles containing glatiramer acetate
MAPI PHARMA LTD0 citations50
US12514908B2Jan 6, 2026
Semaglutide depot systems and use thereof
MAPI PHARMA LTD0 citations48
US10111867B2Oct 30, 2018
Process and intermediates for the preparation of perampanel
MAPI PHARMA LTD0 citations41
US9617241B2Apr 11, 2017
Intermediate compounds and process for the preparation of efinaconazole
MAPI PHARMA LTD0 citations36
MAROM EHUD
8 patentsUS8921415B2Dec 30, 2014
Polymorphs of darunavir
MAROM EHUD6 citations83
US8796226B2Aug 5, 2014
Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof
MAROM EHUD11 citations83
US8735627B2May 27, 2014
Intermediate compounds and process for the preparation of fingolimod
MAROM EHUD4 citations71
US9206197B2Dec 8, 2015
Amorphous form of dolutegravir
MAROM EHUD2 citations62
US8865742B2Oct 21, 2014
Intermediate compounds and processes for the preparation of quinoline derivatives such as Laquinimod sodium
MAROM EHUD3 citations61
US8981095B2Mar 17, 2015
Intermediate compounds and process for the preparation of lurasidone and salts thereof
MAROM EHUD2 citations60
US8410176B2Apr 2, 2013
Intermediate compounds and processes for the preparation of tapentadol and related compounds
MAROM EHUD2 citations60
US8841447B2Sep 23, 2014
Process for the preparation of alogliptin
MAROM EHUD1 citations50
STEM CELL MEDICINE LTD
4 patentsUS11413311B2Aug 16, 2022
Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
STEM CELL MEDICINE LTD2 citations67
US12161688B2Dec 10, 2024
Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
STEM CELL MEDICINE LTD0 citations57
US11510946B2Nov 29, 2022
Treatment of multiple sclerosis with adipose-derived stem cells
STEM CELL MEDICINE LTD0 citations51
US12514815B2Jan 6, 2026
Cosmetic compositions with protein concentrate from conditioned medium of adipose-derived stem cells
STEM CELL MEDICINE LTD0 citations42